SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR
sofosbuvir 400 mg + velpatasvir 100 mg + voxilaprevir 100 mg tablet, 28
SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR (11665Y)
11665Y
Manner of administration:Oral
Restriction
Indication: Chronic hepatitis C infection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 2 | DPMQ: $11,875.00 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Vosevi | |||||
